Delivery Order SPE2DR25D3020-SPE2DR26F9P8E
Award Date 12/9/25
Potential Completion Date 12/10/25
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $6,223.32 for RINVOQ ER 30 mg tablets (30-count units) under a firm fixed price contract type. The award was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside competitive award, reflecting AmerisourceBergen's capability to meet...
- The Defense Logistics Agency awarded a $39,787.21 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) with a completion date of June 2, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply delivery under AmerisourceBergen's broader relationship with the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,605.35 on August 20, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of RINVOQ ER 30 mg tablets in quantities of 30 units. This is a competitively awarded, firm fixed-price delivery order with a ceiling value of $19,727.87 and an ultimate completion date of July 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $7,057.46, for the supply of RINVOQ ER 30 mg tablets (30-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and carries an ultimate completion date of June 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters operations. This delivery order is issued...
- The Defense Logistics Agency awarded a competitively bid delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. The contract, valued at $12,033.52 with a firm fixed-price structure, was awarded on November 25, 2025, with an ultimate completion date of November 26, 2025. This delivery order was issued without a set-aside designation, demonstrating the...
- The Defense Logistics Agency awarded a $21,799.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of RINVOQ ER 30 mg tablets in units of 30. This competitively awarded, non-set-aside contract is scheduled for completion by December 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $6,558.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 8, 2025, with completion targeted for December 9, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively-awarded delivery order by the Defense Logistics Agency on September 26, 2025, for RINVOQ ER 15 mg tablets (30-count units) with a ceiling value of $43,487.57. The contract is structured as a firm fixed-price delivery order under a child contract arrangement, with an ultimate completion date of September 29, 2025. This award carries no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,322.47 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as...